These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 18684504)
1. Myelodysplastic syndrome and pregnancy: case report. Sackmann Massa F; Pavlovsky S Leuk Res; 2009 Mar; 33(3):e23-5. PubMed ID: 18684504 [No Abstract] [Full Text] [Related]
2. Twice-weekly high-dose rHuEpo for the treatment of anemia in patients with low-risk myelodysplastic syndromes. Latagliata R; Oliva EN; Volpicelli P; Carmosino I; Breccia M; Vincelli I; Alati C; Napoleone L; Vozella F; Nobile F; Alimena G Acta Haematol; 2008; 120(2):104-7. PubMed ID: 18974634 [No Abstract] [Full Text] [Related]
3. Efficacy of a combination of human recombinant erythropoietin + 13-cis-retinoic acid and dihydroxylated vitamin D3 to improve moderate to severe anaemia in low/intermediate risk myelodysplastic syndromes. Ferrero D; Darbesio A; Giai V; Genuardi M; Dellacasa CM; Sorasio R; Bertini M; Boccadoro M Br J Haematol; 2009 Feb; 144(3):342-9. PubMed ID: 19036104 [TBL] [Abstract][Full Text] [Related]
4. [Pure red cell aplasia in patient affected by myelodysplastic syndrome treated with R-Epo]. Luraschi A; Montanara S; Fedeli P; Buscaglia P; Fossati O; Cozzi S; Castello A Recenti Prog Med; 2008 May; 99(5):255-7. PubMed ID: 18581968 [TBL] [Abstract][Full Text] [Related]
5. The differential diagnosis between aplastic anemia and hypocellular myelodysplasia in patients with pancytopenia. Lorand-Metze I; Meira DG; Lima CS; Vassallo J; Metze K Haematologica; 1999 Jun; 84(6):564-5. PubMed ID: 10366807 [No Abstract] [Full Text] [Related]
6. Erythrophagocytosis by neoplastic cells in a patient with myelodysplastic syndrome. Ascani S; Sabattini E; Agostinelli C; Piccaluga PP; Zinzani PL; Pileri SA Haematologica; 2004 Apr; 89(4):EIM07. PubMed ID: 15075110 [No Abstract] [Full Text] [Related]
7. Erythropoietin in myelodysplastic syndromes: durable response in a young patient. Aloe Spiriti MA; Latagliata R; Petti MC Haematologica; 1996; 81(4):381-2. PubMed ID: 8870388 [No Abstract] [Full Text] [Related]
8. Apparent vaccine-thimerosal induced hypersensitivity, myelodysplastic syndrome and pancytopenia. Karsen H; Akdeniz H; Karahocagil MH; Baran AI; Erten R J Infect Dev Ctries; 2007 Dec; 1(3):348-9. PubMed ID: 19734619 [TBL] [Abstract][Full Text] [Related]
9. Effect of biscoclaurine alkaloids, prednisolone and ascorbic acid on myelodysplastic syndrome with pancytopenia: a case report. Saito N; Miyamoto M; Gotoh U; Yoshitomi S Eur J Haematol; 2000 Jan; 64(1):61-5. PubMed ID: 10680708 [No Abstract] [Full Text] [Related]
10. Gelatinous degeneration of the bone marrow: two case reports showing different hematological features and clinical outcomes. Niscola P; Maurillo L; Palombi M; Fratoni S; Perrotti AP; Piccioni D; Panetta P; Scaramucci L; Del Poeta G; de Fabritiis P Acta Haematol; 2007; 118(3):165-6. PubMed ID: 17890850 [No Abstract] [Full Text] [Related]
11. Treating low-risk myelodysplastic syndromes in the community setting. Cripe LD Clin Adv Hematol Oncol; 2008 Jun; 6(6):418-20. PubMed ID: 18567986 [No Abstract] [Full Text] [Related]
12. Myelodysplastic syndromes: biology and treatment. Jädersten M; Hellström-Lindberg E J Intern Med; 2009 Mar; 265(3):307-28. PubMed ID: 19141095 [TBL] [Abstract][Full Text] [Related]
13. Stage III melanoma treated with chemotherapy after surgery during the second trimester of pregnancy. Ishida I; Yamaguchi Y; Tanemura A; Hosokawa K; Itami S; Morita A; Katayama I Arch Dermatol; 2009 Mar; 145(3):346-8. PubMed ID: 19289786 [No Abstract] [Full Text] [Related]
15. Neutrophilic panniculitis associated with myelodysplastic syndrome with abnormal nuclear forms. Becherer K; Golda N; Feldman M; Diaz-Arias A; Caldwell C J Cutan Pathol; 2009 Sep; 36(9):1024-6. PubMed ID: 19674208 [No Abstract] [Full Text] [Related]
16. Myelodysplasia or myelodysplastic syndrome? Giagounidis AA Leuk Res; 2009 Aug; 33(8):1019. PubMed ID: 19303635 [No Abstract] [Full Text] [Related]
17. Anti-thymocyte globulin therapy induced a spurious increase of fibrinogen degradation products in hypoplastic myelodysplastic syndrome. Yahata Y; Isobe Y; Sasaki M; Oshimi K; Sugimoto K Eur J Haematol; 2009 May; 82(5):404. PubMed ID: 19191866 [No Abstract] [Full Text] [Related]
18. Disseminated peritoneal leiomyomatosis: a case report. Tripathi M; Singh PA; Tripathi A Indian J Pathol Microbiol; 2007 Apr; 50(2):342-4. PubMed ID: 17883066 [TBL] [Abstract][Full Text] [Related]
19. Myelodysplastic syndromes: more prevalent than we know. Sandhu SK; Sekeres MA Geriatrics; 2008 Nov; 63(11):10-7. PubMed ID: 18998762 [TBL] [Abstract][Full Text] [Related]
20. Transient neonatal myelosuppression after fetal exposure to maternal chemotherapy. Case report and review of the literature. Udink ten Cate FE; ten Hove CH; Nix WM; de Vries JI; van de Loosdrecht AA; van Elburg RM Neonatology; 2009; 95(1):80-5. PubMed ID: 18787341 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]